Studies have shown that coronavirus disease 2019 (COVID-19) and AD share common risk such as age, sex, hypertension, diabetes, APOE 4ε, links with the ACE2 receptor, increased oxidative stress, and obesity [14,15,16,17]. This evidence concerns the gene APOE and COVID-19.